Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
September 23rd, 2021
The protocols describe high-performance liquid chromatography methods coupled to refractive index or mass spectrometric detection for studying metabolic reactions in complex lysate-based cell-free systems.
Overview
This protocol outlines high-performance liquid chromatography methods combined with refractive index and mass spectrometric detection to analyze metabolic reactions in lysate-based cell-free systems. It enables the quantitative assessment of various metabolites, including those present at low concentrations.
Key Study Components
Area of Science
- Biochemistry
- Metabolomics
- Cell-free systems
Background
- Understanding metabolic reactions is crucial for various biological applications.
- Lysate-based systems provide a simplified environment for studying metabolism.
- High-performance liquid chromatography (HPLC) is a powerful analytical technique.
- Mass spectrometry enhances the detection capabilities for metabolites.
Purpose of Study
- To develop a protocol for analyzing metabolic byproducts in cell-free systems.
- To utilize HPLC and mass spectrometry for comprehensive metabolite profiling.
- To enable the detection of metabolites at low concentrations.
Methods Used
- Preparation of reactions in microcentrifuge tubes with specific lysate protein concentrations.
- Termination of reactions using trichloroacetic acid for enzyme precipitation.
- Filtration and transfer of supernatants for HPLC analysis.
- Data acquisition and analysis of chromatograms to identify and quantify metabolites.
Main Results
- Successful detection of key metabolites such as glucose, lactate, and ethanol.
- Demonstration of the protocol's effectiveness in analyzing complex lysate backgrounds.
- Quantitative data generated for metabolites across different time points.
- Validation of manual integration methods for peak analysis.
Conclusions
- The protocol provides a reliable method for studying metabolic reactions in cell-free systems.
- Combining HPLC with mass spectrometry enhances metabolite detection.
- This approach can be applied to various biochemical research areas.
Frequently Asked Questions
Executive Industry Relevance
Metabolite profiling in lysate-based cell-free systems enables rapid design-build-test-learn cycles for metabolic engineering by providing quantitative flux data without host survival constraints. This approach supports early-stage target validation and pathway de-risking in biopharma R&D by delivering reproducible, scalable metabolite measurements from complex lysates. The integration of refractive index and mass spectrometric detection expands analytical coverage for central carbon intermediates and low-abundance products, improving predictive confidence in pathway engineering decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through quantification of central metabolite fluxes in cell-free lysates.
- Operational Value: Supports biological de-risking by isolating pathway activity from cellular homeostasis mechanisms.
- Predictive Value: Generates reproducible flux data to prioritize targets with high conversion efficiency and low byproduct formation.
Screening & Assay Development
- Assay Readiness: Prepares lysates for standardized metabolite screening using HPLC-RID and LC-MS/MS platforms.
- Quantitative Output: Delivers concentration-time profiles of glucose, lactate, ethanol, acetate, succinate, and formate for kinetic modeling.
- Platform Reuse: Establishes a reusable analytical workflow for monitoring engineered pathway performance across multiple DBTL cycles.
Translational & Preclinical Research
- Translational Continuity: Connects discovery-stage flux measurements to preclinical validation by confirming carbon routing from glucose to tyrosine and histidine precursors.
- Mechanistic De-risking: Validates pathway engagement (e.g., glycolysis, pentose phosphate) through 13C-glucose tracing and metabolite annotation.
- Risk-Adjusted Advancement: Identifies metabolic bottlenecks and byproduct accumulation early, informing go/no-go decisions before cellular system implementation.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from hypothesis testing through lead identification by supplying quantitative metabolite data that informs pathway optimization and strain design.
- Discovery Biology: Tests metabolic hypotheses by measuring real-time flux changes in response to lysate modifications or substrate perturbations.
- Screening: Enables assay standardization through consistent sample preparation, enzymatic quenching, and reproducible chromatographic separation.
- Analytics: Provides peak area integration and manual correction capabilities to ensure accurate quantification across low- and high-abundance metabolites.
- Translational Research: Tracks 13C-label incorporation into amino acid precursors, supporting biomarker-aligned pathway validation.
- Enterprise Reuse: Establishes a transferable analytical protocol for lysate characterization that can be deployed across multiple metabolic engineering projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in pathway engineering by reducing mechanistic ambiguity in carbon flux distribution.
- Operational Value: Ensures reproducibility through standardized quenching, filtration, and detection protocols applicable to complex lysate matrices.
- Strategic Value: Improves capital efficiency by enabling rapid iteration in cell-free systems before committing to cellular strain development.
- Portfolio Impact: Supports risk-adjusted prioritization of metabolic routes based on quantified product yields and byproduct profiles.
Implementation Considerations
- Requires expertise in HPLC operation, manual peak integration, and mass spectrometry data annotation.
- Depends on access to HPLC-RID and LC-MS/MS systems with compatible autosamplers and column chemistries.
- Necessitates cross-team standardization of sample preparation, quenching, and filtration steps to ensure data comparability.
- Involves adaptation considerations when transferring protocols between lysate sources or altering metabolite panels of interest.
- Includes practical limitations such as the need for manual integration when automatic peak detection fails in complex chromatograms.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:08
Starting, Stopping, and Processing Time Course CFME Reactions for HPLC-RID Quantification
3:18
Creating a Sequence Table for Autosampling and Start the HPLC-RID System for Data Acquisition
4:54
Extracting and Analyzing Data Post-Run
7:20
Starting, Stopping, and Processing Time Course Isotope Tracing CFME Reactions for LC-MS/MS Quantification
9:20
Setting Up a Run Sequence and Starting the LC-MS/MS Run
10:16
Calculating Negative Mode Masses of 13C-Labeled Glucose-Derived Metabolites and Searching for the m/z Features of These Analytes in Filtered Data
11:45
Results: Metabolite Profiling in Lysate-based Cell-free Systems
13:54
Conclusion
